Search research articles
Contact Us
Filters
Showing results (111-120 of 145) with videos related to
Page
of 15
Sort By:
British Journal of Cancer
|
March 1, 2003
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy
I Ray-Coquard, C Borg, Th Bachelot, et al.
La Revue De Medecine Interne
|
November 28, 2015
[Association of lymphoma and granulomatosis: A case series]
F de Charry, K Sadoune, C Sebban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte
H Tilly, N Mounier, P Lederlin, et al.
Extremophiles : Life Under Extreme Conditions
|
July 1, 2021
Glutamate optimizes enzymatic activity under high hydrostatic pressure in Desulfovibrio species: effects on the ubiquitous thioredoxin system
H Gaussier, M Nouailler, E Champaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 15, 2005
Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol
M Diviné, P Casassus, S Koscielny, et al.
Presse Medicale (Paris, France : 1983)
|
January 15, 2000
[Standards, options and recommendations for the management of adult patients with Hodgkin disease. Standards, Options and Recommendations (SOR) in Cancerology. Groupe d'Etude des Lymphomes de l'Adulte]]
C Fermé, J M Cosset, B Fervers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2006
Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma
F Morschhauser, S Depil, E Jourdan, et al.
British Journal of Cancer
|
May 18, 2001
Hodgkins disease
C Ferme, J M Cosset, B Fervers, et al.
Blood
|
June 14, 2000
Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA)
N Mounier, C Haioun, B F Cole, et al.
Leukemia
|
March 3, 2006
High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)
E Jabbour, S Koscielny, C Sebban, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 145) with videos related to
Sort By:
Page
of 15
British Journal of Cancer
|
March 1, 2003
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy
I Ray-Coquard, C Borg, Th Bachelot, et al.
La Revue De Medecine Interne
|
November 28, 2015
[Association of lymphoma and granulomatosis: A case series]
F de Charry, K Sadoune, C Sebban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte
H Tilly, N Mounier, P Lederlin, et al.
Extremophiles : Life Under Extreme Conditions
|
July 1, 2021
Glutamate optimizes enzymatic activity under high hydrostatic pressure in Desulfovibrio species: effects on the ubiquitous thioredoxin system
H Gaussier, M Nouailler, E Champaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 15, 2005
Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol
M Diviné, P Casassus, S Koscielny, et al.
Presse Medicale (Paris, France : 1983)
|
January 15, 2000
[Standards, options and recommendations for the management of adult patients with Hodgkin disease. Standards, Options and Recommendations (SOR) in Cancerology. Groupe d'Etude des Lymphomes de l'Adulte]]
C Fermé, J M Cosset, B Fervers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2006
Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma
F Morschhauser, S Depil, E Jourdan, et al.
British Journal of Cancer
|
May 18, 2001
Hodgkins disease
C Ferme, J M Cosset, B Fervers, et al.
Blood
|
June 14, 2000
Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA)
N Mounier, C Haioun, B F Cole, et al.
Leukemia
|
March 3, 2006
High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)
E Jabbour, S Koscielny, C Sebban, et al.
Page
of 15